Indometacin farnesil
(Redirected from Indomethacin farnesil)
Template:Short description Template:Cs1 config Template:Drugbox
Indometacin farnesil (INN) is a prodrug of the nonsteroidal anti-inflammatory drug (NSAID) indometacin,[1] designed to reduce the occurrence of side-effects by esterification of the carboxyl group on indometacin with farnesol. Indometacin farnesil was first approved in Japan in 1991, and is available in Japan[2] and Indonesia, under the trade names Infree and Dialon, respectively.
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox". Template:Prostanoidergics